With no end in sight. Momentum works both ways.
Any competition at all and the stock drops below $3/share. As it stands, with real revenue not realized until late 2014, the PPS could drop to $5/share by Spring. It's still unclear how big the liver assay market will be.
I enjoyed part of the ride up and will simply watch any decline from the sidelines.
Probably not much intelligence or imagination at that school if they are more concerned with after school sports. (Not that I don't believe that "balance" is a key to successful education.)
So why are you still hanging around? At what point do you cover?
I agree with your assessment.
Unfortunately, I took a position at $124.50 this morning. But I do believe I'll be green again within a week (or less). Anything below $120 is a good entry point, IMHO.
VJET and ONVO both "jumped to the moon."
But now they're bringing the entire 3D sector back to Earth.
Anything below $120 is a very entry point for SSYS, IMHO.
Again, be warned. I help this stock and rode it up like the rest of us. But I'm now out.
I love the value proposition of the company, but there are entities out there that want to manipulate the stock lower. I'm not sure what the bottom is, but we won't hit it today.
My only concern right now is not to be tempted to "temporarily borrow funds" from my KERX holdings to purchase more attractive swing-tradable stocks. To do so risks being "out of KERX" at the worst possible time. So far, I've avoided the temptation.
Long and strong!
A Seeking Alpha writer under the pseudonym ("Alpha Exposure") might be at this very moment writing a "hit piece" against Organovo. Actually, the article may already be written; he may just be waiting for the appropriate moment to release it to Seeking Alpha.
I've seen this writer destroy stock prices of other companies. He recently Stocktwitted that he has a $1-2 target price for ONVO.
Do you plan to sell either right before or after the Japanese approval (assuming it comes) or will you hold all of the way through FDA approval (assuming it comes)?